POSITION:HOME / Industry news
Industry news

2017, the 6 major trends in the medical device industry overall analysis!

In the past six years, China's medical technology and medical equipment industry has been growing rapidly. It is estimated that the market size of China's medical technology and medical equipment market will reach 600 billion yuan in 2019. In the face of such a large dividend, it is particularly important to grasp the mainstream direction, whether to follow the trend of dividends or fall behind others? It's up to you.

 

In 2011 -2016, China's medical technology and medical equipment industry average annual compound growth rate of 20.7%, in 2016 China's medical technology and medical equipment market size of about 370 billion yuan, compared with 2015 growth of 62 billion yuan, the annual growth rate of about 20.1%. Among them, imaging equipment, in vitro diagnostics and high-value consumables occupy the top three segments of medical technology and medical device market, accounting for 19%, 16% and 13% of the total market size, respectively.

 

However, from the instruments proportion, 1:7 is China's medical market and medical market scale, far below the global 1:3. From the per capita medical technology and medical equipment costs, China's current per capita cost only $6, while the developed countries per capita costs are more than $100 U.S. $329 / person, Switzerland is up to 513 dollars / person. Therefore, no matter from the methods of diagnosis and treatment, or from the consumption level to measure, China medical environment is far lower than other countries, but Chinese population, medical technology and medical market of our country is absolutely impressive, if a large growth space, has brought considerable benefits for our dealers! Where are the key points that we focus on? Grasp these to grab more benefits!
  

Medical technology and medical device Market

 

In recent years, with the development of China, the country's investment in medical technology and medical equipment industry has become more and more vigorous. Ordinary people have a feeling, not to mention the dealers in the deep industry
Whether it is optimized, medical examination and approval procedures of centralized procurement of medical consumables and online transactions, or two votes and support the domestic medical equipment, is hitherto unknown!
Of course, in addition to the national policy, our aging population gradually increased, the per capita number of visits and medical costs continue to increase, also continuing to promote the rapid growth of China's medical technology and medical device industry!

 

In 2017, six major trends led the industry

Two vote system fully implemented to promote channel change
2016's hot topic is the two vote, the major dealers from all don't believe and questioned the attitude, and now has comprehensive prevention, after all, Fujian and Zhejiang has issued a document, if this continues, large enterprises will be the channel sink, small and medium sized agents will be eliminated a number, or a group of the transformation of a number of. Under this trend, there will be three major trends in the industry: horizontal acquisition, vertical extension and transformation.
Transformation: refers to the transformation between medical equipment manufacturing enterprises and channel type business model, such as some instruments dealers in the two vote system, replacing business tax with value-added tax(VAT) and regulation under the background of the transformation of CSO; part of commercial equipment agency in the background or the transformation of distribution business.
In short, the channels of mergers and acquisitions, extension, and transformation will make the channel link gradually to focus, which is the future of two channels under the direction of channel integration.
Grading treatment brings opportunities for domestic equipment
From the beginning of last year, efforts to support domestic medical equipment increase gradually in our country, such as excellent domestic Yixie special approval system innovation and preferential, part of the province the number is set to purchase domestic Yixie number, especially China's basic medical is developing rapidly, so the grading treatment can not only give the development of domestic equipment to bring the opportunity to promote the great for China's basic medical environment, improve the medical environment. This will not only break the situation that our high-end medical equipment market has been monopolized by foreign enterprises for a long time, but also promote the development of China's primary medical care environment!
So, we will focus on the inspection of diagnostic equipment (especially POCT and fast testing equipment etc.), chronic disease related to household appliances, medical rehabilitation equipment, medical equipment, follow-up follow-up ultrasound safe and simple imaging equipment and other basic equipment.
Instrument based third party services
Where there is interest, there is a market, with the deepening of the medical reform and continuous exploration of various new mode for hospital services, hospital, and win-win "mutual benefit model", than leather hospital life, grab hospital business "subversion" mode is more in line with the current health care business environment, under the various third party service apparatus based on will have a brilliant future, thinking and mode of various kinds of "Internet plus" will be integrated into the service.
From the Planning Commission for third party diagnosis, imaging and pathology of the third party issued a document in support of that diagnosis, medical devices and equipment, imaging and pathology of logistics, disinfection, maintenance, equipment packaging and other intensive emerging service model will greatly promote the development of the medical industry based on. As these sectors are also capital intensive industries, there is a strong belief that there will be a lot of investment and mergers and acquisitions.
New technologies penetrate the field of instruments
Early screening technology, artificial intelligence, 3D printing, medical robots, etc. will bring about a subversive revolution in diagnosis and treatment.
The so-called "not in the development of innovation," in the old-fashioned death! China's medical environment has indeed started late in other developed countries, but we are on the shoulders of giants! While improving their own environment at the same time, but also with the development of different times, so these new medical technology and medical equipment, will be born trillion blue ocean market.
Precision medical gradually from concept to maturity
From January 2015, President Obama proposed "precise medical plan", "precision medical" has gradually become popular vocabulary in the medical field, with NGS, DNA, gene editing capture technology continues to mature. Precision medical care has gradually matured from concept to maturity. From the process of diagnosis and treatment, accurate medical treatment can be divided into early screening, disease diagnosis and prognosis follow-up.
In recent years, with the "precision medical" concept in China's widespread dissemination, "precision medical" cause has also been significant development. Shanghai power to precise medical specimen collection system, gene detection reagents and consumables, assisted reproductive products, sample pretreatment system, POCT reagent, special equipment manufacturing six series of products and sincerely look forward to working with the medical industry Tongren sincere cooperation and make contributions to our people's health cause.
Overseas investment and M & a momentum continues to be strong
Since the end of 2016, investment institutions and large enterprises in the market of medical equipment investment, to pay attention to the robustness, sales profit, have stable mature channels of investment opportunities, and began to actively seek overseas technology companies to invest in the introduction of products, and is complementary with the domestic channel advantage.
Since 2016, nine medical 93 million 880 thousand euros to buy eDevice, overweight medical testing equipment; the acquisition of purple Xin Pharmaceutical Nabsys2.0, enter the gene detection; BOE $50 million investment in Israel noninvasive medical equipment company Cnoga; Sannuo acquisition of U.S. biological diagnosis of PTS for $200 million, POCT diagnosis to enter the field of IVD industry. In vitro diagnosis, gene sequencing, innovative medical equipment as a technical barrier, high growth rate of hot areas, is the leading acquisition of the battleground. 2017 will be another year for the domestic leaders to compete in the layout of the overseas.